Spero Therapeutics (SPRO) EBITDA Margin Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -932.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,003.00 |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | 302,717.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 302,717.00 |
| Dec 31, 2025 | -58,693.00 |
| Sep 30, 2025 | 43,654.00 |
| Jun 30, 2025 | 142,161.00 |
| Mar 31, 2025 | 133,612.00 |
| Dec 31, 2024 | 10,543.00 |
| Sep 30, 2024 | -3.18 Mn |
| Jun 30, 2024 | 55,891.00 |
| Mar 31, 2024 | 11,513.00 |
| Sep 30, 2023 | 4.84 Mn |
| Jun 30, 2023 | 57,275.00 |
| Mar 31, 2023 | -457,951.00 |
| Dec 31, 2022 | 374,982.00 |
| Sep 30, 2022 | -20,068.00 |
| Jun 30, 2022 | 1.82 Mn |
| Mar 31, 2022 | -152,156.00 |
| Dec 31, 2021 | 43,736.00 |
| Sep 30, 2021 | 477,227.00 |
| Jun 30, 2021 | 126,549.00 |
| Sep 30, 2020 | -4.82 Mn |
| Jun 30, 2020 | 290,948.00 |
| Mar 31, 2020 | 320,991.00 |
| Dec 31, 2019 | -1.71 Mn |
| Sep 30, 2019 | 753,267.00 |